Risk–benefit analysis of COVID-19 vaccines — a neurological perspective

Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk–benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Colleen L., Galea, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687148/
https://www.ncbi.nlm.nih.gov/pubmed/34931027
http://dx.doi.org/10.1038/s41582-021-00606-5
_version_ 1784618154395172864
author Lau, Colleen L.
Galea, Ian
author_facet Lau, Colleen L.
Galea, Ian
author_sort Lau, Colleen L.
collection PubMed
description Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk–benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors to inform decision-making and support the global vaccination effort.
format Online
Article
Text
id pubmed-8687148
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86871482021-12-21 Risk–benefit analysis of COVID-19 vaccines — a neurological perspective Lau, Colleen L. Galea, Ian Nat Rev Neurol News & Views Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk–benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors to inform decision-making and support the global vaccination effort. Nature Publishing Group UK 2021-12-20 2022 /pmc/articles/PMC8687148/ /pubmed/34931027 http://dx.doi.org/10.1038/s41582-021-00606-5 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News & Views
Lau, Colleen L.
Galea, Ian
Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
title Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
title_full Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
title_fullStr Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
title_full_unstemmed Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
title_short Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
title_sort risk–benefit analysis of covid-19 vaccines — a neurological perspective
topic News & Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687148/
https://www.ncbi.nlm.nih.gov/pubmed/34931027
http://dx.doi.org/10.1038/s41582-021-00606-5
work_keys_str_mv AT laucolleenl riskbenefitanalysisofcovid19vaccinesaneurologicalperspective
AT galeaian riskbenefitanalysisofcovid19vaccinesaneurologicalperspective

Ejemplares similares